Todos Medical Ltd.
TOMDF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.02 | 0.00 | -0.00 |
| FCF Yield | -21.97% | -31.26% | -25.92% | -34.70% |
| EV / EBITDA | -5.43 | -7.31 | -1.20 | -0.97 |
| Quality | ||||
| ROIC | -243.89% | -196.41% | -1,553.49% | 214.85% |
| Gross Margin | 56.01% | 35.84% | 26.68% | 0.00% |
| Cash Conversion Ratio | 0.11 | 0.26 | 0.09 | 0.11 |
| Growth | ||||
| Revenue 3-Year CAGR | 13.90% | – | – | – |
| Free Cash Flow Growth | 77.38% | -144.56% | -294.42% | -19.19% |
| Safety | ||||
| Net Debt / EBITDA | -4.08 | -3.25 | -0.42 | -0.49 |
| Interest Coverage | -0.66 | -0.30 | -4.08 | -3.67 |
| Efficiency | ||||
| Inventory Turnover | 3.32 | 4.90 | 7.12 | 0.00 |
| Cash Conversion Cycle | -552.19 | 43.90 | -79.05 | -5,103.33 |